Pulmatrix and Cullgen Announce Proposed Merger
In 2023 Cullgen completed a Series C financing led by AstraZeneca-CICC Venture Capital Partnership, and also announced a strategic partnership with Astellas Pharma Inc.
Yahoo Finance1h
Marvel Biosciences Corp. to Present at the Life Sciences Investor Forum November 14th
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If ...